Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

West Pharmaceutical Services, Inc. Common Stock (NY:WST)

223.03 +0.77 (+0.34%)
Streaming Delayed Price Updated: 12:32 PM EDT, Jul 7, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about West Pharmaceutical Services, Inc. Common Stock

< Previous 1 2
...
7 8 9 10 11 12 13 14 Next >
Stocks That Hit 52-Week Lows On Wednesday
During Wednesday's trading, 435 companies set new 52-week lows. 
Via Benzinga
West Pharmaceutical Services Shares Slides Post Q1 Results
Via Benzinga
Earnings Scheduled For February 17, 2022
Companies Reporting Before The Bell • Palantir Technologies (NYSE:PLTR) is estimated to report quarterly earnings at $0.04 per share on revenue of $417.69 million. 
Via Benzinga
Earnings Scheduled For October 28, 2021
Companies Reporting Before The Bell • LendingTree (NASDAQ:TREE) is estimated to report quarterly earnings at $0.57 per share on revenue of $292.63 million. •... 
Via Benzinga
West Pharmaceutical Servs: Q1 Earnings Insights
West Pharmaceutical Servs (NYSE:WST) reported its Q1 earnings results on Thursday, April 28, 2022 at 06:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Earnings Scheduled For April 28, 2022
Companies Reporting Before The Bell • PBF Energy (NYSE:PBF) is projected to report quarterly earnings at $0.26 per share on revenue of $8.24 billion. 
Via Benzinga
Becton Dickinson Stock Near High, Hits 80-Plus RS Rating
Becton Dickinson stock shows improving price performance, earning an upgrade to its IBD Relative Strength Rating from 76 to 82. 
Via Investor's Business Daily
19 Dividend Stocks That Pay In February, May, August And November
Looking to fill in your dividend calendar? These top dividend stocks pay quarterly. 
Via Talk Markets
7 Healthcare Stocks to Buy for the Long Term
When the markets go through the massive transitions they're seeing right now, it's a great time to add quality healthcare stocks. 
Via InvestorPlace
Ominous Death Cross Forms On West Pharmaceutical Servs's Chart
If history is any guide, there may be trouble ahead for shares of West Pharmaceutical Servs (NYSE:WST). A so-called "death cross" has formed on its chart and, not surprisingly,... 
Via Benzinga
The Daily Biotech Pulse: J&J Unit Announces Research Collaboration With Remix, Regencell Touts COVID Data, Decision Day For Agios
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Amylyx's ALS Treatment Regulatory Application To Be Reviewed By FDA Panel... 
Via Benzinga
West Pharmaceutical's Q4 Performance Surpass Expectations, Expects FY22 Sales To Increase 8%
West Pharmaceutical Services Inc's (NYSE: WST) Q4 net s 
Via Benzinga
West Pharmaceutical Servs: Q4 Earnings Insights
  West Pharmaceutical Servs (NYSE:WST) reported its Q4 earnings results on Thursday, February 17, 2022 at 06:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
The Week Ahead In Biotech (Feb. 13-19): Agios FDA Meeting, Avenue Adcom, Earnings And More
Biotech stocks moved back and forth amid some volatility before finishing the week ending Feb. 11 modestly lower, reversing the gains from the previous week. Earnings news... 
Via Benzinga
26 Firms Going Ex-Dividend Next Week, Including CVS Health, APA Corp. And Procter & Gamble
There are several well known large cap stocks going ex-dividend next week including 4 of our Top 100 Dividend Stocks. 
Via Talk Markets
West Pharmaceutical Servs's Ex-Dividend Date Is Monday, Here's What You Need To Know
Monday marks the last chance for investors to receive the next dividend payout from West Pharmaceutical Servs. What's Happening 
Via Benzinga
Microsoft, Google Lead 5 Long-Term Leaders Near Buy Points
Microsoft has formed a flat base amid solid growth. Google is actionable now. 
Via Investor's Business Daily
$1000 Invested In This Stock Over The Last 15 Years, Would Be Worth This Much
West Pharmaceutical Servs (NYSE:WST) has outperformed the market over the past 15 years by 12.76% on an annualized basis. Buying $1,000 In WST: 15 years ago, an investor could... 
Via Benzinga
Here's How Much You Would Have Made Owning West Pharmaceutical Servs Stock In The Last 15 Years
West Pharmaceutical Servs (NYSE:WST) has outperformed the market over the past 15 years by 12.12% on an annualized basis. Buying $1,000 In WST: 15 years ago, an investor could... 
Via Benzinga
When Winning Streaks Stop: Trying To Beat The Market By Buying Stocks Like Tesla
Teslas getting charged in a Wawa parking lot last month. Photo via author. When Winning Streaks Stop In a post in August (Tesla And The Quest For Alpha), we wrote about how a... 
Via Benzinga
When Winning Streaks Stop
Trying to beat the market by buying stocks like Tesla. It's probably impossible to time these things perfectly, but as we continue to collect data, we may be able to spend more time in winning... 
Via Talk Markets
West Pharmaceutical Services (WST) Q3 2021 Earnings Call Transcript
WST earnings call for the period ending September 30, 2021. 
Via The Motley Fool
Topics Earnings
West Pharmaceutical Services: Q3 Earnings Insights
West Pharmaceutical Servs (NYSE:WST) reported its Q3 earnings results on Thursday, October 28, 2021 at 06:00 AM. Here's what investors need to know about the... 
Via Benzinga
West Pharmaceutical Servs's Earnings: A Preview
West Pharmaceutical Servs (NYSE:WST) is set to give its latest quarterly earnings report on Thursday, 2021-10-28. Here's what investors need to know before the announcement.... 
Via Benzinga
3 Healthcare Stocks to Buy and Hold for the Next 10 Years
Consistency is the main attraction for these companies. 
Via The Motley Fool
The Daily Biotech Pulse: Apellis Sinks On Data, Endo Shines On Opioid Litigation Settlement, T2 Biosystems Soars On Mutant Detection Ability of COVID Test
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 9) Adagio Therapeutics, Inc. (... 
Via Benzinga
The Daily Biotech Pulse: ProQR-Lilly R&D Partnership, Sanofi's Pemphigus Trial Disappointment, Humanigen's COVID-19 Drug Denied Emergency Use Authorization
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 8) Abbott Laboratories (NYSE:... 
Via Benzinga
The Daily Biotech Pulse: Cellect Jumps On First Apograft Transplantation, AstraZeneca, European Commission Bury Legal Hatchet, Cassava Defends Itself
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 2) Abbott Laboratories (NYSE:... 
Via Benzinga
The Daily Biotech Pulse: Merck Releases Twin Dose Of Positive Tidings, Astellas Voluntarily Pauses Gene Therapy Study, Ascendis Offering
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 31) AC Immune SA (NASDAQ: ACIU... 
Via Benzinga
The Daily Biotech Pulse: VectivBio In M&A Mix, Sonnet Biotherapeutics Advances Candidate To Clinics, CEO Transitions At Galapagos, Talis Biomedical
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 26) Agenus Inc. (NASDAQ: AGEN)... 
Via Benzinga
< Previous 1 2
...
7 8 9 10 11 12 13 14 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.